title: Epigenetics of schizophrenia: an open and shut case.
abstract: During the last decade and a half, there has been an explosion of data regarding epigenetic changes in schizophrenia. Most initial studies have suggested that schizophrenia is characterized by an overly restrictive chromatin state based on increases in transcription silencing histone modifications and DNA methylation at schizophrenia candidate gene promoters and increases in the expression of enzymes that catalyze their formation. However, recent studies indicate that the pathology is more complex. This complexity may greatly impact pharmacological approaches directed at targeting epigenetic abnormalities in schizophrenia. The current review explores epigenetic studies of schizophrenia and what this can tell us about the underlying pathophysiology. We hypothesize based on recent studies that it is also plausible that drugs that further restrict chromatin may be efficacious.
authors.affiliation: Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA; Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA. Electronic address: dgavin@psych.uic.edu.
authors.forename: David P
authors.initials: DP
authors.lastname: Gavin
authors.affiliation: Department of Psychiatry, University of Illinois at Chicago, Chicago, Illinois, USA; Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA.
authors.forename: Christina
authors.initials: C
authors.lastname: Floreani
mesh_terms: D000818:Animals; D018899:CpG Islands / Q000235:genetics; D019175:DNA Methylation; D044127:Epigenesis, Genetic / Q000502:physiology*; D006801:Humans; D012559:Schizophrenia / Q000235:genetics* / Q000503:physiopathology*
keywords: Bipolar disorder; CpG methylation; Demethylation; GADD45; Psychosis